<DOC>
	<DOCNO>NCT01782079</DOCNO>
	<brief_summary>The aim study select optimal condition quantification oral cavity Lactobacillus brevis CD2 , probiotic strain contain commercially available dietary supplement ass persistency oral administration . Different set primer L. brevis detection test real-time PCR reaction find optimal amplification efficiency target specificity . Primers ability identification L. brevis DNA assess pilot study conduct 12 healthy volunteer clinically free oral pathology . The subject take 3 tablets/day 3 day one tablet 4th day . Clinical sample ( dorsal surface tongue , first molar , vestibular fornix saliva ) collect baseline ( begin trial ) , T0 ( morning assumption last tablet ) 3 , 6 , 9 hour take last tablet . The quantity L. brevis DNA compare total number bacteria present sample . The activity enzyme arginine deiminase , responsible oral pH homeostasis ( particularly abundant CD2 strain ) also assess saliva sample treatment , HPLC measurement .</brief_summary>
	<brief_title>L. Brevis CD2 Strain Persistence Oral Cavity</brief_title>
	<detailed_description />
	<criteria>Age &gt; 18 year Healthy subject oral cavity pathology Written inform consent Patients oral disease Patients systemic disease Celiac patient subject affect allergic reaction soy protein Use antibiotic probiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Lactobacillus brevis</keyword>
	<keyword>Oral health</keyword>
	<keyword>Bacterial adhesion</keyword>
</DOC>